Seeking to accelerate the process of getting new vaccines to market, PRA Health Sciences partnered with the Alliance for Multispecialty Research to look for ways to help vaccine studies run more efficiently and effectively.
PRA partners up to accelerate vaccine R&D;
PRA Health Sciences has joined forces with a trial site group to focus on vaccine development, hoping to speed up patient recruitment and get more clinical studies rolling.
PRA adding 150 jobs amid Pennsylvania expansion push
PRA Health Sciences is building up its presence in Pennsylvania, adding 150 jobs with plans to dial up recruitment over the next two years.
PRA boosts its profit forecast after a strong sales quarter
PRA Health Sciences is ticking up its full-year expectations after another quarter of revenue growth, counting on a steady stream of new business.
PRA doubles down on the hunt for new R&D; talent
PRA Health Sciences, looking to find the next generation of clinical researchers, is dialing up its recruitment pitch in hopes of meeting the escalating demand for CRO-run trials around the world.
PRA debuts a sweeping clinical trial operating system
PRA Health Sciences, a year removed from its $300 million IPO, unveiled an end-to-end technology platform that pools trial design, planning and monitoring in one place, touting its new offering as a major step forward for the CRO.
PRA posts a big quarter despite the bite of currency fluctuations
PRA Health Sciences shook off the effects of a surging dollar to pull off 7% revenue growth in the first quarter, kicking off the year with its largest ever backlog.
PRA bets big on Phase I studies with a new outpost and global expansions
In its first big move since pulling off a $306 million IPO, PRA Health Sciences is stretching out its early-stage development efforts, expanding its Phase I heft around the world.
After a $300M IPO, PRA forecasts a big 2015
PRA Health Sciences, the latest CRO to go public, is expecting up to 10% revenue growth in 2015, hoping to top a transformational year that reshaped its business.
CRO IPOs get a warm reception as PRA, INC boom on the Street
PRA Health Sciences and INC Research have both seen their shares tick upward since pulling off IPOs earlier this month, a sign that, despite biotech's boom and bust, the window for CRO debuts remains open.